GGrantIndex
← Leaderboards

Timothy R Dillingham

Johns Hopkins University

$9,957,953
Attributed
$10,697,951
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,697,951 · 9
VA$0 · 1

By mechanism

R01$3,851,089 · 3
R42$3,685,347 · 3
SB1$2,881,748 · 1
R29$179,767 · 1
R41$100,000 · 1
I01$0 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Cost

Research focus

CostAmputationInterestDesignLower ExtremityQuality Of LifePersonsBiomechanicsMoldsDevicesProsthesisInnovationBusinessesGaitEffectivenessInternationalCost EffectivenessGrowthProspectiveBaseProgramsCost EffectivePolymersMeetings

Grant awards (25)

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled$501,301
R01 · FY2025 · HD · contact PI
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled$642,659
R01 · FY2024 · HD · contact PI
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth$883,271
R42 · FY2023 · HD · contact PI
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering from Post-acute Sequelae of SARS-CoV-2 infection (PASC): A Randomized Controlled$696,313
R01 · FY2023 · HD · contact PI
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth$880,549
R42 · FY2022 · HD · contact PI
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes$370,936
R01 · FY2021 · AG · contact PI
Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth$292,648
R42 · FY2021 · HD · contact PI
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes$234,086
R01 · FY2020 · AG · contact PI
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS$957,487
SB1 · FY2019 · AG · contact PI
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes$419,236
R01 · FY2019 · AG · contact PI
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS$969,437
SB1 · FY2018 · AG · contact PI
Evaluating the Effects of CMS' Prospective Episode-Based "Bundling" Payment Model for Lower Limb Joint Replacement: Post-acute Care Setting, Costs and Patient Outcomes$455,738
R01 · FY2018 · AG · contact PI
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS$954,824
SB1 · FY2017 · AG · contact PI
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY TRANSTIBIAL PROSTHESIS$486,732
R42 · FY2016 · AG · contact PI
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY TRANSTIBIAL PROSTHESIS$474,565
R42 · FY2015 · AG · contact PI
Immediate fit using innovative technology, transtibial prosthesis$308,096
R42 · FY2013 · HD · contact PI
Immediate fit using innovative technology transtibial prosthesis$359,486
R42 · FY2012 · HD · contact PI
Immediate fit using innovative technology, transtibial prosthetic system$100,000
R41 · FY2011 · HD · contact PI
Guitars for Vets: Evaluating psychological outcomes of a novel music therapy$0
I01 · FY2011 · VA · contact PI
Dysvascular Amputees: Rehabilitation Use and Outcomes$165,274
R01 · FY2004 · HD
Dysvascular Amputees: Rehabilitation Use and Outcomes$160,462
R01 · FY2003 · HD
DYSVASCULAR AMPUTEES: REHABILITATION USE AND OUTCOMES$83,366
R01 · FY2002 · HD
DYSVASCULAR AMPUTEES: REHABILITATION USE AND OUTCOMES$121,718
R01 · FY2001 · HD
DYSVASCULAR AMPUTEES: REHABILITATION USE AND OUTCOMES$26,852
R29 · FY2001 · HD
DYSVASCULAR AMPUTEES: REHABILITATION USE AND OUTCOMES$152,915
R29 · FY2000 · HD